{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:39:29Z","timestamp":1791337169337,"version":"4.3.1"},"reference-count":160,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Antimicrobial resistance (AMR) constitutes a critical and escalating global public health challenge, severely limiting the potential of existing antimicrobial drugs and escalating infection-associated morbidity and mortality rates. This analysis focuses on the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which are prioritized by the World Health Organization (WHO) and represent a significant cause of nosocomial infections due to their extensive drug resistance. We provide an in-depth review of the global prevalence and specific antibiotic-resistant mechanisms of these pathogens. Due to the decline in the traditional antibiotic development pipeline, accelerated development of alternative therapeutic strategies is essential. The review comprehensively discusses innovative non-traditional therapies currently being explored to bypass traditional antibiotic limitations, such as phage therapy, antimicrobial peptides (AMPs), anti-virulence therapies, fecal microbiota transplantation (FMT), and targeted CRISPR-based approaches. Addressing the ESKAPE challenge requires a concerted, multi-sectoral strategy guided by the One Health principle, focusing on enhancing public awareness, improving surveillance and research, optimizing judicious antibiotic use, and cultivating sustainable investment in novel interventions.<\/jats:p>","DOI":"10.3390\/antibiotics15060550","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:50:28Z","timestamp":1780447828000},"page":"550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The ESKAPE Challenge: Understanding Resistance and Exploring Alternative Treatments"],"prefix":"10.3390","volume":"15","author":[{"given":"Kartika","family":"Vashishtha","sequence":"first","affiliation":[{"name":"Department of Development Biology and Genetics, Indian Institute of Science, C.V. Raman Avenue, Bangalore 560012, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pobitra","family":"Borah","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, Uttar Pradesh, India"},{"name":"Department of Pharmacology, Pratiksha Institute of Pharmaceutical Sciences, Chandrapur Road, Panikhaiti, Guwahati 781026, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sonowal","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial Resistance Worldwide: Causes, Challenges and Responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/clpt.2009.122","article-title":"Clinical Challenges in Addressing Resistance to Antimicrobial Drugs in the Twenty-First Century","volume":"86","author":"Septimus","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the Mechanisms and Drivers of Antimicrobial Resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1901872","DOI":"10.1002\/advs.201901872","article-title":"Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections","volume":"7","author":"Ma","year":"2020","journal-title":"Adv. Sci."},{"key":"ref_5","unstructured":"WHO (2022, December 23). WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. Available online: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","unstructured":"(2025, December 16). WHO Bacterial Priority Pathogens List. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114006","DOI":"10.1016\/j.ijheh.2022.114006","article-title":"Prevalence of ESKAPE Pathogens in the Environment: Antibiotic Resistance Status, Community-Acquired Infection and Risk to Human Health","volume":"244","author":"Denissen","year":"2022","journal-title":"Int. J. Hyg. Env. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/655995","article-title":"Progress and Challenges in Implementing the Research on ESKAPE Pathogens","volume":"31","author":"Rice","year":"2010","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2475067","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41564-024-01891-8","article-title":"ESKAPE Pathogens Rapidly Develop Resistance against Antibiotics in Development in Vitro","volume":"10","author":"Daruka","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s44259-025-00123-1","article-title":"Current Economic and Regulatory Challenges in Developing Antibiotics for Gram-Negative Bacteria","volume":"3","author":"Gargate","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100705","DOI":"10.1016\/j.lanepe.2023.100705","article-title":"Challenges and Opportunities for Incentivising Antibiotic Research and Development in Europe","volume":"33","author":"Anderson","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.22207\/JPAM.11.2.17","article-title":"Molecular Characterization of Resistance Genes in MDR-ESKAPE Pathogens","volume":"11","author":"Navidinia","year":"2018","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref_16","unstructured":"Gilmore, M.S., Clewell, D.B., Ike, Y., and Shankar, N. (2014). Enterococcus Diversity, Origins in Nature, and Gut Colonization. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Massachusetts Eye and Ear Infirmary."},{"key":"ref_17","unstructured":"Gilmore, M.S., Clewell, D.B., Ike, Y., and Shankar, N. (2014). Enterococcal Infection\u2014Treatment and Antibiotic Resistance. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Massachusetts Eye and Ear Infirmary."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","article-title":"Molecular Mechanisms of Vancomycin Resistance","volume":"29","author":"Stogios","year":"2020","journal-title":"Protein Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jochim-Vukosavic, A., Schwab, F., Knegendorf, L., Schl\u00fcter, D., Bange, F.-C., Ebadi, E., and Baier, C. (2024). Epidemiology and Infection Control of Vancomycin-Resistant Enterococci at a German University Hospital: A Three-Year Retrospective Cohort Study. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0297866"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinids\/22.4.663","article-title":"Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus Faecium or Vancomycin-Susceptible E. Faecium","volume":"22","author":"Linden","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0196-6553(96)90025-5","article-title":"Experience with a Hospital-Wide Outbreak of Vancomycin-Resistant Enterococci","volume":"24","author":"Quale","year":"1996","journal-title":"Am. J. Infect. Control"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/clinids\/24.3.514","article-title":"Recurrent Vancomycin-Resistant Enterococcus Faecium Bacteremia in a Leukemia Patient Who Was Persistently Colonized with Vancomycin-Resistant Enterococci for Two Years","volume":"24","author":"Roghmann","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0140-6736(96)02331-8","article-title":"Epidemiology of Colonisation of Patients and Environment with Vancomycin-Resistant Enterococci","volume":"348","author":"Bonten","year":"1996","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical Relevance of the ESKAPE Pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.5005\/jp-journals-10071-23916","article-title":"Increasing Trend of Vancomycin-Resistant Enterococci Bacteremia in a Tertiary Care Hospital of South India: A Three-Year Prospective Study","volume":"25","author":"Sivaradjy","year":"2021","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","article-title":"The Ongoing Challenge of Vancomycin-Resistant Enterococcus Faecium and Enterococcus Faecalis in Europe: An Epidemiological Analysis of Bloodstream Infections","volume":"9","author":"Ayobami","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13756-018-0384-3","article-title":"Enumerating the Economic Cost of Antimicrobial Resistance per Antibiotic Consumed to Inform the Evaluation of Interventions Affecting Their Use","volume":"7","author":"Shrestha","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101663","DOI":"10.1016\/j.cegh.2024.101663","article-title":"Vancomycin-Resistant Enterococci: A Rising Challenge to Global Health","volume":"28","author":"Iqbal","year":"2024","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"103111","DOI":"10.1016\/j.jiph.2025.103111","article-title":"Global Burden, Inequalities and Projections of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis, 1990\u20132050: A Systematic Global Analysis","volume":"19","author":"Qiu","year":"2026","journal-title":"J. Infect. Public Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"a026989","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1016\/0002-9343(91)90346-Y","article-title":"Major Trends in the Microbial Etiology of Nosocomial Infection","volume":"91","author":"Schaberg","year":"1991","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0966-842X(96)10063-9","article-title":"Glycopeptide Resistance in Enterococci","volume":"4","author":"Arthur","year":"1996","journal-title":"Trends Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/978-0-387-78885-2_14","article-title":"Biotechnology and Biological Sciences Research Council, UK Vancomycin Resistance VanS\/VanR Two-Component Systems","volume":"631","author":"Hong","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10408","DOI":"10.1021\/bi00107a007","article-title":"Molecular Basis for Vancomycin Resistance in Enterococcus Faecium BM4147: Biosynthesis of a Depsipeptide Peptidoglycan Precursor by Vancomycin Resistance Proteins VanH and VanA","volume":"30","author":"Bugg","year":"1991","journal-title":"Biochemistry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1365-2958.1994.tb00497.x","article-title":"Glycopeptide Resistance Mediated by Enterococcal Transposon Tn1546 Requires Production of VanX for Hydrolysis of D-Alanyl-D-Alanine","volume":"13","author":"Reynolds","year":"1994","journal-title":"Mol. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/AAC.36.1.77","article-title":"Inducible Carboxypeptidase Activity in Vancomycin-Resistant Enterococci","volume":"36","author":"Gutmann","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0378-1119(94)00851-I","article-title":"The vanZ Gene of Tn1546 from Enterococcus Faecium BM4147 Confers Resistance to Teicoplanin","volume":"154","author":"Arthur","year":"1995","journal-title":"Gene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2958.1996.00617.x","article-title":"Quantitative Analysis of the Metabolism of Soluble Cytoplasmic Peptidoglycan Precursors of Glycopeptide-Resistant Enterococci","volume":"21","author":"Arthur","year":"1996","journal-title":"Mol. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/CMR.3.1.46","article-title":"The Life and Times of the Enterococcus","volume":"3","author":"Murray","year":"1990","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0378-1119(93)90779-3","article-title":"The vanB Gene of Vancomycin-Resistant Enterococcus Faecalis V583 Is Structurally Related to Genes Encoding D-Ala:D-Ala Ligases and Glycopeptide-Resistance Proteins VanA and VanC","volume":"124","author":"Evers","year":"1993","journal-title":"Gene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-94-6-784","article-title":"Enterococcal Superinfection and Colonization After Therapy with Moxalactam, a New Broad-Spectrum Antibiotic","volume":"94","author":"Yu","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S708","DOI":"10.1093\/clinids\/4.Supplement_3.S708","article-title":"Enterococcal Infections in Patients Treated with Moxalactam","volume":"4","author":"Moellering","year":"1982","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archinte.1993.00410130103010","article-title":"Cephalosporins as Risk Factor for Nosocomial Enterococcus Faecalis Bacteremia. A Matched Case-Control Study","volume":"153","author":"Pallares","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(60)91642-1","article-title":"Bacteriological Studies on a New Penicillin-BRL. 1241","volume":"2","author":"Rolinson","year":"1960","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.1993.03500050076029","article-title":"The Epidemiology of Intravenous Vancomycin Usage in a University Hospital. A 10-Year Study","volume":"269","author":"Ena","year":"1993","journal-title":"JAMA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0025-7125(16)30041-4","article-title":"Vancomycin","volume":"79","author":"Cunha","year":"1995","journal-title":"Med. Clin. N. Am."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3201\/eid0702.010237","article-title":"Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus Aureus","volume":"7","author":"Tenover","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_48","unstructured":"Centers for Disease Control and Prevention (CDC) (2002). Staphylococcus Aureus Resistant to Vancomycin\u2014United States, 2002. MMWR Morb. Mortal. Wkly. Rep., 51, 565\u2013567."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0140-6736(05)78597-4","article-title":"Vancomycin-Resistant Staphylococcus Aureus","volume":"351","author":"Howe","year":"1998","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(05)79166-2","article-title":"First Clinical Isolate of Vancomycin-Intermediate Staphylococcus Aureus in a French Hospital","volume":"351","author":"Ploy","year":"1998","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s100960050380","article-title":"Presence of Staphylococcus Aureus with Reduced Susceptibility to Vancomycin in Germany","volume":"18","author":"Bierbaum","year":"1999","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global Prevalence and Distribution of Vancomycin Resistant, Vancomycin Intermediate and Heterogeneously Vancomycin Intermediate Staphylococcus Aureus Clinical Isolates: A Systematic Review and Meta-Analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13756-023-01210-6","article-title":"The Global Prevalence of Methicillin-Resistant Staphylococcus Aureus Colonization in Residents of Elderly Care Centers: A Systematic Review and Meta-Analysis","volume":"12","author":"Hasanpour","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_54","unstructured":"Antimicrobial Resistance Collaborators (2022). Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet, 399, 629\u2013655."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3184\/003685002783238870","article-title":"Methicillin Resistance in Staphylococcus Aureus: Mechanisms and Modulation","volume":"85","author":"Stapleton","year":"2002","journal-title":"Sci. Prog."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41586-021-04265-w","article-title":"Emergence of Methicillin Resistance Predates the Clinical Use of Antibiotics","volume":"602","author":"Larsen","year":"2022","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1473-3099(11)70126-8","article-title":"Meticillin-Resistant Staphylococcus Aureus with a Novel mecA Homologue in Human and Bovine Populations in the UK and Denmark: A Descriptive Study","volume":"11","author":"Holden","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.vetmic.2017.06.004","article-title":"High Occurrence of mecC-MRSA in Wild Hedgehogs (Erinaceus Europaeus) in Sweden","volume":"207","author":"Bengtsson","year":"2017","journal-title":"Vet. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rasmussen, S.L., Larsen, J., van Wijk, R.E., Jones, O.R., Berg, T.B., Angen, \u00d8., and Larsen, A.R. (2019). European Hedgehogs (Erinaceus Europaeus) as a Natural Reservoir of Methicillin-Resistant Staphylococcus Aureus Carrying mecC in Denmark. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222031"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin Resistant Staphylococcus Aureus Infections: A Review of Case Updating and Clinical Features","volume":"21","author":"Cong","year":"2019","journal-title":"J. Adv. Res."},{"key":"ref_61","first-page":"269","article-title":"Vancomycin Resistance in Staphylococcus Aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/jb.175.1.117-127.1993","article-title":"Characterization of Tn1546, a Tn3-Related Transposon Conferring Glycopeptide Resistance by Synthesis of Depsipeptide Peptidoglycan Precursors in Enterococcus Faecium BM4147","volume":"175","author":"Arthur","year":"1993","journal-title":"J. Bacteriol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-Type Vancomycin-Resistant Staphylococcus Aureus","volume":"53","author":"Courvalin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1128\/AAC.00185-10","article-title":"Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus Aureus","volume":"54","author":"Zhu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Nocera, F.P., Attili, A.-R., and De Martino, L. (2021). Acinetobacter Baumannii: Its Clinical Significance in Human and Veterinary Medicine. Pathogens, 10.","DOI":"10.3390\/pathogens10020127"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"102430","DOI":"10.1016\/j.pdpdt.2021.102430","article-title":"Antimicrobial Photodynamic Therapy against Acinetobacter baumannii","volume":"35","author":"Mencalha","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/IDR.S228089","article-title":"Acinetobacter Baumannii Efflux Pumps and Antibiotic Resistance","volume":"13","author":"Abdi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Codjoe, F.S., and Donkor, E.S. (2017). Carbapenem Resistance: A Review. Med. Sci., 6.","DOI":"10.3390\/medsci6010001"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/jcm.34.6.1519-1525.1996","article-title":"Comparison of Outbreak and Nonoutbreak Acinetobacter Baumannii Strains by Genotypic and Phenotypic Methods","volume":"34","author":"Dijkshoorn","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resmic.2003.10.003","article-title":"Identification of a New Geographically Widespread Multiresistant Acinetobacter Baumannii Clone from European Hospitals","volume":"155","author":"Dijkshoorn","year":"2004","journal-title":"Res. Microbiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e02260-23","DOI":"10.1128\/mbio.02260-23","article-title":"A Global View on Carbapenem-Resistant Acinetobacter baumannii","volume":"14","author":"Reuter","year":"2023","journal-title":"mBio"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chukamnerd, A., Surachat, K., Pomwised, R., Palittapongarnpim, P., Singkhamanan, K., and Chusri, S. (2026). Genomic Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand. Antibiotics, 15.","DOI":"10.20944\/preprints202601.1521.v1"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2049936115621709","article-title":"Carbapenem Resistance: Overview of the Problem and Future Perspectives","volume":"3","author":"Meletis","year":"2016","journal-title":"Ther. Adv. Infect."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Lee, C.-R., Lee, J.H., Park, M., Park, K.S., Bae, I.K., Kim, Y.B., Cha, C.-J., Jeong, B.C., and Lee, S.H. (2017). Biology of Acinetobacter Baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front. Cell Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00055"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Sheu, C.-C., Chang, Y.-T., Lin, S.-Y., Chen, Y.-H., and Hsueh, P.-R. (2019). Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00080"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1128\/AAC.00459-11","article-title":"Analysis of Genes Encoding Penicillin-Binding Proteins in Clinical Isolates of Acinetobacter Baumannii","volume":"55","author":"Espinal","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem Resistance in Acinetobacter Baumannii: Mechanisms and Epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"106049","DOI":"10.1016\/j.micpath.2023.106049","article-title":"Molecular Docking and Dynamic Approach to Screen the Drug Candidate against the Imipenem-Resistant CarO Porin in Acinetobacter Baumannii","volume":"177","author":"Gopikrishnan","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkf043","article-title":"Molecular Characterization of Metallo-b-Lactamase-Producing Acinetobacter Baumannii and Acinetobacter Genomospecies 3 from Korea: Identification of Two New Integrons Carrying the blaVIM-2 Gene Cassettes","volume":"49","author":"Yum","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1128\/AAC.49.11.4485-4491.2005","article-title":"Novel Acquired Metallo-\u03b2-Lactamase Gene, BlaSIM-1, in a Class 1 Integron from Acinetobacter Baumannii Clinical Isolates from Korea","volume":"49","author":"Lee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","unstructured":"Wilson, M.G., and Pandey, S. (2025). Pseudomonas Aeruginosa. StatPearls, StatPearls Publishing."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"106196","DOI":"10.1016\/j.ijantimicag.2020.106196","article-title":"Pseudomonas Aeruginosa Epidemic High-Risk Clones and Their Association with Horizontally-Acquired \u03b2-Lactamases: 2020 Update","volume":"56","author":"Oliver","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_83","unstructured":"(2025, March 06). CHINET Data Cloud\/Antibiotic Resistance. Available online: https:\/\/www.chinets.com\/Data\/AntibioticDrugFast."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Huang, W., Wei, X., Xu, G., Zhang, X., and Wang, X. (2023). Carbapenem-Resistant Pseudomonas Aeruginosa Infections in Critically Ill Children: Prevalence, Risk Factors, and Impact on Outcome in a Large Tertiary Pediatric Hospital of China. Front. Public. Health, 11.","DOI":"10.3389\/fpubh.2023.1088262"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jgar.2023.06.013","article-title":"Temporal and Geographical Prevalence of Carbapenem-Resistant Pseudomonas Aeruginosa and the in Vitro Activity of Ceftolozane\/Tazobactam and Comparators in Taiwan\u2014SMART 2012\u20132021","volume":"34","author":"Karlowsky","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/ijmr.IJMR_1_18","article-title":"Phenotypic & Genotypic Profile of Antimicrobial Resistance in Pseudomonas Species in Hospitalized Patients","volume":"149","author":"Bajpai","year":"2019","journal-title":"Indian. J. Med. Res."},{"key":"ref_87","unstructured":"(2025, March 05). Surveillance of Antimicrobial Resistance in Europe 2018. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2018."},{"key":"ref_88","first-page":"1","article-title":"Antimicrobial-Resistant Pathogens Associated with Adult Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network, 2015\u20132017","volume":"41","author":"Abner","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3201\/eid2911.230646","article-title":"Domestically Acquired NDM-1\u2013Producing Pseudomonas aeruginosa, Southern California, USA, 2023","volume":"29","author":"Gray","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-018-3244-4","article-title":"Molecular Epidemiology of Carbapenem-Resistant Pseudomonas Aeruginosa in an Endemic Area: Comparison with Global Data","volume":"37","author":"Karampatakis","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/504477","article-title":"Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas Aeruginosa","volume":"43","author":"Bonomo","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo-\u03b2-Lactamases: The Quiet before the Storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_93","unstructured":"(2025, March 08). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2019. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2019."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Yoon, E.-J., and Jeong, S.H. (2021). Mobile Carbapenemase Genes in Pseudomonas Aeruginosa. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.614058"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"ARBA-0026-2017","DOI":"10.1128\/microbiolspec.ARBA-0026-2017","article-title":"Antimicrobial Resistance in Escherichia coli","volume":"6","author":"Poirel","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"100312","DOI":"10.1016\/j.infpip.2023.100312","article-title":"An Observational Study on Carbapenem-Resistant Enterobacterales (CRE) Colonisation and Subsequent Risk of Infection in an Adult Intensive Care Unit (ICU) at a Tertiary Care Hospital in India","volume":"5","author":"Sharma","year":"2023","journal-title":"Infect. Prev. Pract."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2147\/CIA.S406214","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae Infection and Its Risk Factors in Older Adult Patients","volume":"18","author":"Kacar","year":"2023","journal-title":"Clin. Interv. Aging"},{"key":"ref_98","first-page":"81","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae Bacteremia: Counterbalance between the Endemic Load and the Infection Control Program in a Hospital","volume":"69","author":"Papanikolopoulou","year":"2024","journal-title":"Acta Microbiol. Hell."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s15010-023-02094-9","article-title":"Ceftazidime-Avibactam Alone or in Combination with Aztreonam versus Polymyxins in the Management of Carbapenem-Resistant Klebsiella Pneumoniae Nosocomial Infections (CAPRI Study): A Retrospective Cohort Study from South India","volume":"52","author":"Sree","year":"2024","journal-title":"Infection"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14787210.2024.2305854","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae: The Role of Plasmids in Emergence, Dissemination, and Evolution of a Major Clinical Challenge","volume":"22","author":"Pollini","year":"2024","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Karampatakis, T., Tsergouli, K., and Behzadi, P. (2023). Carbapenem-Resistant Klebsiella Pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020234"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","article-title":"International and Regional Spread of Carbapenem-Resistant Klebsiella Pneumoniae in Europe","volume":"15","author":"Kostyanev","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"T\u00fczemen, N.\u00dc., \u00d6nal, U., Merdan, O., Akca, B., Ener, B., Akal\u0131n, H., and \u00d6zak\u0131n, C. (2024). Performance Comparison of BD Phoenix CPO Detect Panel with Cepheid Xpert Carba-R Assay for the Detection of Carbapenemase-Producing Klebsiella Pneumoniae Isolates. BMC Microbiol., 24.","DOI":"10.1186\/s12866-024-03311-7"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13643-022-02110-3","article-title":"Prevalence and Incidence of Carbapenem-Resistant K. Pneumoniae Colonization: Systematic Review and Meta-Analysis","volume":"11","author":"Tesfa","year":"2022","journal-title":"Syst. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Paauw, A., Caspers, M.P.M., Schuren, F.H.J., Leverstein-van Hall, M.A., Del\u00e9toile, A., Montijn, R.C., Verhoef, J., and Fluit, A.C. (2008). Genomic Diversity within the Enterobacter Cloacae Complex. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003018"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"16173","DOI":"10.1038\/nmicrobiol.2016.173","article-title":"The Dissemination of Multidrug-Resistant Enterobacter Cloacae throughout the UK and Ireland","volume":"1","author":"Moradigaravand","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3201\/eid2406.171648","article-title":"Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008\u20132014","volume":"24","author":"Peirano","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e02093-16","DOI":"10.1128\/mBio.02093-16","article-title":"Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms","volume":"7","author":"Chavda","year":"2016","journal-title":"mBio"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e00542-18","DOI":"10.1128\/mBio.00542-18","article-title":"Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant Enterobacter Cloacae Complex Clones ST171 and ST78","volume":"9","author":"Annavajhala","year":"2018","journal-title":"mBio"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e00079-17","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae","volume":"31","author":"Machuca","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eimc.2013.10.008","article-title":"First Detection and Characterization of an OXA-48-Producing Enterobacter Aerogenes Isolate","volume":"32","author":"Torres","year":"2014","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s13730-018-0360-z","article-title":"NDM-1-Producing Enterobacter Aerogenes Isolated from a Patient with a JJ Ureteric Stent in Situ","volume":"8","author":"Beader","year":"2019","journal-title":"CEN Case Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2147\/IDR.S235975","article-title":"Carbapenem-Resistant Klebsiella Aerogenes Clinical Isolates from a Teaching Hospital in Southwestern China: Detailed Molecular Epidemiology, Resistance Determinants, Risk Factors and Clinical Outcomes","volume":"13","author":"Ma","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and Clinical Epidemiology of Carbapenem-Resistant Enterobacterales in the USA (CRACKLE-2): A Prospective Cohort Study","volume":"20","author":"Arias","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE Pathogens: Antimicrobial Resistance, Epidemiology, Clinical Impact and Therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_117","unstructured":"(2025, May 21). Opportunities for Diagnostic Stewardship in Clinical Microbiology. Available online: https:\/\/asm.org:443\/articles\/2021\/april\/opportunities-for-diagnostic-stewardship-in-clinic."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13756-019-0590-7","article-title":"Economic Burden of Antibiotic Resistance in ESKAPE Organisms: A Systematic Review","volume":"8","author":"Zhen","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"dlad124","DOI":"10.1093\/jacamr\/dlad124","article-title":"Addressing Antimicrobial Resistance through Community Engagement: A Framework for Developing Contextually Relevant and Impactful Behaviour Change Interventions","volume":"5","author":"Mitchell","year":"2023","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"106467","DOI":"10.1016\/j.micpath.2023.106467","article-title":"Bacteriophage Therapy against ESKAPE Bacterial Pathogens: Current Status, Strategies, Challenges, and Future Scope","volume":"186","author":"Kulshrestha","year":"2024","journal-title":"Microb. Pathog."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1071\/MA11090","article-title":"Bacteriophage Taxonomy","volume":"32","author":"Ackermann","year":"2011","journal-title":"Microbiol. Aust."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Pallavali, R.R., Degati, V.L., Lomada, D., Reddy, M.C., and Durbaka, V.R.P. (2017). Isolation and in Vitro Evaluation of Bacteriophages against MDR-Bacterial Isolates from Septic Wound Infections. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179245"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12223-018-0636-x","article-title":"Isolation, Characterization and Efficacy of Phage MJ2 against Biofilm Forming Multi-Drug Resistant Enterobacter Cloacae","volume":"64","author":"Jamal","year":"2019","journal-title":"Folia Microbiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12223-018-0622-3","article-title":"Antimicrobial Effect of Commercial Phage Preparation Stafal\u00ae on Biofilm and Planktonic Forms of Methicillin-Resistant Staphylococcus Aureus","volume":"64","year":"2019","journal-title":"Folia Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"123965","DOI":"10.1016\/j.biortech.2020.123965","article-title":"Pyophage Cocktail for the Biocontrol of Membrane Fouling and Its Effect in Aerobic Microbial Biofilm Community during the Treatment of Antibiotics","volume":"318","author":"Aydin","year":"2020","journal-title":"Bioresour. Technol."},{"key":"ref_126","unstructured":"(2025, November 12). Pyofag\u00ae. Available online: https:\/\/bacteriophages.info\/en\/bacteriophage\/piofag\/."},{"key":"ref_127","unstructured":"(2025, November 12). Sextaphage\u00ae Polyvalent Pyobacteriophage. Available online: https:\/\/www.microgen.ru\/en\/products\/bakteriofagi\/sekstafag-piobakteriofag-polivalentnyy\/."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Mishra, S.K., Akter, T., Urmi, U.L., Enninful, G., Sara, M., Shen, J., Suresh, D., Zheng, L., Mekonen, E.S., and Rayamajhee, B. (2025). Harnessing Non-Antibiotic Strategies to Counter Multidrug-Resistant Clinical Pathogens with Special Reference to Antimicrobial Peptides and Their Coatings. Antibiotics, 14.","DOI":"10.3390\/antibiotics14010057"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage Therapy: From Biological Mechanisms to Future Directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e37489","DOI":"10.1016\/j.heliyon.2024.e37489","article-title":"Bacteriophage as a Potential Biotherapeutics to Combat Present-Day Crisis of Multi-Drug Resistant Pathogens","volume":"10","author":"Pattnaik","year":"2024","journal-title":"Heliyon"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Mulani, M.S., Kamble, E.E., Kumkar, S.N., Tawre, M.S., and Pardesi, K.R. (2019). Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00539"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Huan, Y., Kong, Q., Mou, H., and Yi, H. (2020). Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.582779"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/psc.2947","article-title":"Computational Resources and Tools for Antimicrobial Peptides","volume":"23","author":"Liu","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijantimicag.2009.10.015","article-title":"The Designer Proline-Rich Antibacterial Peptide A3-APO Is Effective against Systemic Escherichia Coli Infections in Different Mouse Models","volume":"35","author":"Szabo","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bip.21443","article-title":"Intramuscularly Administered Peptide A3-APO Is Effective Against Carbapenem-Resistant Acinetobacter Baumannii in Mouse Models of Systemic Infections","volume":"96","author":"Ostorhazi","year":"2011","journal-title":"Biopolymers"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2013.08.001","article-title":"Rapid Systemic and Local Treatments with the Antibacterial Peptide Dimer A3-APO and Its Monomeric Metabolite Eliminate Bacteria and Reduce Inflammation in Intradermal Lesions Infected with Propionibacterium acnes and Meticillin-Resistant Staphylococcus aureus","volume":"42","author":"Ostorhazi","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"fty072","DOI":"10.1093\/femspd\/fty072","article-title":"Efficacy of Designer K11 Antimicrobial Peptide (a Hybrid of Melittin, Cecropin A1 and Magainin 2) against Acinetobacter Baumannii-Infected Wounds","volume":"76","author":"Rishi","year":"2018","journal-title":"Pathog. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Chatupheeraphat, C., Peamchai, J., Luk-In, S., and Eiamphungporn, W. (2023). Synergistic Effect and Antibiofilm Activity of the Antimicrobial Peptide K11 with Conventional Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant Klebsiella Pneumoniae. Front. Cell Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1153868"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"116001","DOI":"10.1016\/j.ejmech.2023.116001","article-title":"Novel Antimicrobial Peptides Modified with Fluorinated Sulfono-\u03b3-AA Having High Stability and Targeting Multidrug-Resistant Bacteria Infections","volume":"264","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bsheal.2025.01.006","article-title":"Targeting Anti-Virulence Factor Strategies of Bacterial Pathogens","volume":"7","author":"Li","year":"2025","journal-title":"Biosaf. Health"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"127345","DOI":"10.1016\/j.micres.2023.127345","article-title":"Anti-Virulence Compounds against Staphylococcus Aureus Associated with Bovine Mastitis: A New Therapeutic Option?","volume":"271","author":"Sabino","year":"2023","journal-title":"Microbiol. Res."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Sheldon, J.R., and Skaar, E.P. (2020). Acinetobacter Baumannii Can Use Multiple Siderophores for Iron Acquisition, but Only Acinetobactin Is Required for Virulence. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008995"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41429-023-00621-2","article-title":"A Novel Antivirulent Compound Fluorothiazinone Inhibits Klebsiella Pneumoniae Biofilm in Vitro and Suppresses Model Pneumonia","volume":"76","author":"Tsarenko","year":"2023","journal-title":"J. Antibiot."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"107068","DOI":"10.1016\/j.micpath.2024.107068","article-title":"Anti-Bacteria, Anti-Biofilm, and Anti-Virulence Activity of the Synthetic Compound MTEBT-3 against Carbapenem-Resistant Klebsiella Pneumoniae Strains ST3984","volume":"197","author":"Zhang","year":"2024","journal-title":"Microb. Pathog."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.18683\/germs.2022.1328","article-title":"Anti-Virulence Therapeutic Strategies against Bacterial Infections: Recent Advances","volume":"12","author":"Dehbanipour","year":"2022","journal-title":"Germs"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Ben\u00edtez-Chao, D.F., Le\u00f3n-Buitimea, A., Lerma-Escalera, J.A., and Morones-Ram\u00edrez, J.R. (2021). Bacteriocins: An Overview of Antimicrobial, Toxicity, and Biosafety Assessment by in Vivo Models. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.630695"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/ETLS20160015","article-title":"Bacteriocins: Antibiotics in the Age of the Microbiome","volume":"1","author":"Egan","year":"2017","journal-title":"Emerg. Top. Life Sci."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Gradisteanu Pircalabioru, G., Popa, L.I., Marutescu, L., Gheorghe, I., Popa, M., Czobor Barbu, I., Cristescu, R., and Chifiriuc, M.-C. (2021). Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020196"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00203-024-04152-8","article-title":"The Clinical Praxis of Bacteriocins as Natural Anti-Microbial Therapeutics","volume":"206","author":"Nisar","year":"2024","journal-title":"Arch. Microbiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5946\/ce.2024.270","article-title":"Fecal Microbiota Transplantation: Present and Future","volume":"58","author":"Cha","year":"2025","journal-title":"Clin. Endosc."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal Microbiota Transplantation: Current Challenges and Future Landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/07853890.2021.1927170","article-title":"Is There a Role of Faecal Microbiota Transplantation in Reducing Antibiotic Resistance Burden in Gut? A Systematic Review and Meta-Analysis","volume":"53","author":"Dharmaratne","year":"2021","journal-title":"Ann. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e058124","DOI":"10.1136\/bmjopen-2021-058124","article-title":"Randomised, Double-Blind, Placebo-Controlled, Phase 2, Superiority Trial to Demonstrate the Effectiveness of Faecal Microbiota Transplantation for Selective Intestinal Decolonisation of Patients Colonised by Carbapenemase-Producing Klebsiella Pneumoniae (KAPEDIS)","volume":"12","author":"Cano","year":"2022","journal-title":"BMJ Open"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Zohra, T., Numan, M., Ikram, A., Salman, M., Khan, T., Din, M., Salman, M., Farooq, A., Amir, A., and Ali, M. (2021). Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR\/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens. Microorganisms, 9.","DOI":"10.3390\/microorganisms9050954"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Junaid, M., Thirapanmethee, K., Khuntayaporn, P., and Chomnawang, M.T. (2023). CRISPR-Based Gene Editing in Acinetobacter Baumannii to Combat Antimicrobial Resistance. Pharmaceuticals, 16.","DOI":"10.3390\/ph16070920"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s41182-025-00728-2","article-title":"Reinvigorating AMR Resilience: Leveraging CRISPR\u2013Cas Technology Potentials to Combat the 2024 WHO Bacterial Priority Pathogens for Enhanced Global Health Security\u2014A Systematic Review","volume":"53","author":"Okesanya","year":"2025","journal-title":"Trop. Med. Health"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e00843-20","DOI":"10.1128\/AAC.00843-20","article-title":"CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae","volume":"64","author":"Hao","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jmii.2023.10.010","article-title":"CRISPR\/Cas13-Assisted Carbapenem-Resistant Klebsiella Pneumoniae Detection","volume":"57","author":"Cao","year":"2024","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e34383","DOI":"10.1016\/j.heliyon.2024.e34383","article-title":"The Application of CRISPR-Cas System in Staphylococcus Aureus Infection","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/mdr.2017.0147","article-title":"Vancomycin-Resistant Enterococci: A Review of Antimicrobial Resistance Mechanisms and Perspectives of Human and Animal Health","volume":"24","author":"Ahmed","year":"2018","journal-title":"Microb. Drug Resist."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:53:29Z","timestamp":1780635209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":160,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["antibiotics15060550"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15060550","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}